Research Articles
Hairpin Loops in Primer Design: A Complete Guide for Robust PCR and qPCR
This article provides a comprehensive guide for researchers and drug development professionals on hairpin loops in primer design.
Beyond Phosphotyrosine: Evaluating the Lipid-Binding Properties of SH2 Domains in Signal Transduction and Drug Discovery
This article provides a comprehensive evaluation of the lipid-binding properties of different SH2 domain types, a paradigm-shifting function beyond their canonical role as phosphotyrosine readers.
Comparative Screening of STAT-Specific SH2 Domain Inhibitors: Strategies for Achieving Selectivity in Drug Discovery
This article provides a comprehensive overview of the strategies and challenges in developing selective inhibitors for Signal Transducer and Activator of Transcription (STAT) proteins by targeting their Src Homology 2...
Activating vs. Inactivating STAT SH2 Domain Mutations: Mechanisms, Methods, and Clinical Implications
This article provides a comprehensive analysis of gain-of-function (GOF) and loss-of-function (LOF) mutations within the STAT protein SH2 domain, a critical hotspot in oncology and immunology.
Validating SH2 Domain Mutation Effects on STAT Dimerization: From Molecular Mechanisms to Therapeutic Targeting
This article provides a comprehensive resource for researchers and drug development professionals investigating how mutations in the Src Homology 2 (SH2) domain impact Signal Transducer and Activator of Transcription (STAT)...
Structural Divergence and Functional Specialization: A Comparative Analysis of STAT and Src-Family SH2 Domains
This article provides a comprehensive comparative analysis of the Src Homology 2 (SH2) domains found in STAT and Src-family proteins, two classes of proteins central to cellular signaling.
Navigating Selectivity: A Comprehensive Guide to Cross-Reactivity Profiling of STAT SH2 Domain Inhibitors
The development of selective inhibitors for STAT (Signal Transducer and Activator of Transcription) SH2 domains represents a promising therapeutic strategy for cancers and inflammatory diseases.
Achieving Specificity: A Comprehensive Guide to Validating STAT SH2 Domain Inhibitors Across the STAT Family
The development of specific STAT SH2 domain inhibitors represents a promising therapeutic strategy for cancers and inflammatory diseases.
Small Molecule vs. Peptidomimetic SH2 Domain Inhibitors: A Strategic Comparison for Targeted Drug Discovery
This article provides a comprehensive comparison for researchers and drug development professionals on two primary strategies for inhibiting SH2 domain-mediated protein-protein interactions: small molecules and peptidomimetics.
STAT1 vs STAT3 SH2 Domain Specificity: Structural Insights, Inhibitor Design, and Therapeutic Implications
This review provides a comprehensive comparative analysis of the Src Homology 2 (SH2) domains of STAT1 and STAT3, transcription factors critical in immunity, inflammation, and cancer.